van den Broek-Altenburg E, Atherly A, Holladay E
Kamemoto, K., Tataka, Y., Hiratsu, A., Nagayama, C., Hamada, Y., Kurata, K., Chiyoda, M., Ito, M
"Someone has to have a BMI of 30 or above, or BMI of 27 to 30 with complications of obesity." Novo Nordisk, the company that makes both Ozempic and Wegovy, has experienced shortages of both drugs intermittently over the past several months
Key Benefits of BPC 157 Injections Injectable delivery bypasses digestion and may allow for greater systemic exposure compared to oral forms
The medications have different molecular structures and mechanisms, so the numbers arent directly comparable
This extended half-life supports its use as a once-weekly subcutaneous injection, a key feature for patient adherence and convenience